Mesoblast Limited
NASDAQ:MESOBiotechnology
+$0.26 today
- Market cap
- $1.51B
- Beta
- 0.79
- P/E (TTM)
- -23.6
- EPS (TTM)
- -$0.06
Volume 0.13M
Average 0.21M
MESO Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Mesoblast LimitedNASDAQ: MESO
Change in Working Capital · Q4 FY2026 · quarter ended Jun 2026
Change in working capital growth accelerates
Q4 FY2026 change in working capital of $8.97M (cash outflow) rose 69.8% year over year, ahead of the -44.2% change in trailing-twelve-month change in working capital.
Context
- Change in working capital amounted to 0.0% of revenue in FY2026, down 17.7 pp from a year earlier.
- Change in working capital increased in 1 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +69.8% holds above the trailing-twelve-month pace of -44.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2026
- 0 USD
- Year-over-year change
- +100.0%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 0 | +100.0% |
| FY2025 | 2025-06-30 | (3.04M) | -15.6% |
| FY2024 | 2024-06-30 | (2.63M) | -6.4% |
| FY2023 | 2023-06-30 | (2.47M) | -150.8% |
| FY2022 | 2022-06-30 | 4.87M | — |
Change in Working Capital vs competitors
How MESO compares with its peers on the latest reported figures
- MESO's LTM Jun 2026 change in working capital of $8.97M is the 3rd largest of the 6 companies compared; the peer median is $4.33M.
- Its year-over-year change of -44.2% is the 4th highest of 6, against a peer median of +63.3%.
- Change in working capital amounts to 7.5% of revenue for MESO, versus a peer median of 49.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $301.51M | +166.3% | — | 22.2% | |
| LTM Dec 2025 | $33.59M | +63.3% | — | 126.5% | |
| LTM Jun 2026 | $8.97M | -44.2% | — | 7.5% | |
| LTM Mar 2026 | $4.45M | +88.9% | — | 30.1% | |
| LTM Mar 2026 | $4.33M | -45.5% | -52.4% | 68.6% | |
| LTM Mar 2026 | $1.52M | -58.9% | -24.9% | — | |
| Peer median (excluding MESO) | $4.33M | +63.3% | -38.6% | 49.4% | |
Competitors are the stored peer set for MESO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Net Income | (91.35M) | (81.89M) | (87.96M) | (102.14M) | 0 |
| Depreciation & Amortization | 4.38M | 4.11M | 4.67M | 6.4M | 0 |
| Deferred Income Tax | (235K) | (212K) | (191K) | 330K | 0 |
| Stock-Based Compensation | 5.54M | 3.66M | 5.87M | 22.09M | 0 |
| Change in Working Capital | 4.87M | (2.47M) | (2.63M) | (3.04M) | 0 |
| Accounts Receivables | 140K | (118K) | (15.47M) | 6.29M | 0 |
| Inventory | 0 | 0 | 0 | 826K | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 4.73M | (2.35M) | 12.84M | (10.16M) | 0 |
| Other Non-Cash Items | 11.02M | 13.54M | 31.78M | 26.41M | (43.83M) |
| Operating Cash Flow | (65.78M) | (63.27M) | (48.46M) | (49.95M) | (43.83M) |
| Capital Expenditures | (232K) | (314K) | (331K) | (730K) | (898K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | (125K) |
| Sales of Investments | 0 | 120K | 234K | 241K | 0 |
| Other Investing Activities | (75K) | 120K | (60K) | 559K | (65K) |
| Investing Cash Flow | (232K) | (194K) | (97K) | 120K | (1.02M) |
| Debt Repayment | (6.33M) | (2.66M) | (13.52M) | (9.77M) | (5.94M) |
| Common Stock Issued | 209K | 88.64M | 65.41M | 161.21M | 14.24M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.75M) | (11.48M) | (11.63M) | (4.1M) | (23.64M) |
| Financing Cash Flow | (9.87M) | 74.5M | 40.25M | 147.34M | (15.33M) |
| Effect of Forex Changes | (550K) | (168K) | (55K) | 1.09M | 1.55M |
| Net Change in Cash | (76.43M) | 10.87M | (8.36M) | 98.59M | (58.64M) |
| Free Cash Flow | (66.01M) | (63.58M) | (48.79M) | (50.68M) | (44.73M) |
Mesoblast Limited
NASDAQ:MESO
Intrinsic Alpha fair value
Locked
Current Price
$11.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.